Bioactive Materials Market - Global Industry Analysis, Size, Share, Trends, Analysis, Growth, and Forecast 2017 - 2025
Owing to the application of bioactive materials in various biomechanical and biochemical purposes, it makes for an evolving market scenario wherein a few players have moderate stronghold. Research and development is at the backbone of the global bioactive materials market, and hence only those players who have economies of scale and proprietorship of latest technologies can lead. Currently, the competition in the bioactive materials market is largely consolidated with Zimmer and Biomet recently joining hands and now holding the lion share. The merger of these two companies in 2015 is expected to have far-reaching consequences on the structure of the bioactive materials market in the near future.
Product differentiation is another vital aspect of the bioactive materials market. Apart from Zimmer Biomet, some of the other key vendors holding notable shares in the global bioactive materials market are Stryker, Kyocera, DePuy Synthes, and Medtronic, and each of these companies hold their market position via different products for targeted segment consumers. Some of the other prominent players in the global bioactive materials market are arthrex, AAP implantate, 3DI, berkeley advanced, baxter (apatech), biomaterials, biomatlante, biocomposites, Ceraver, and CAM Bioceramics.
This report contains profiles of most of these companies, aspiring to represent the competitive scenario and the product portfolio of these market leaders. The report also provides quantitative and qualitative estimations of the global bioactive materials market, doing so via proven research methodologies. Various factors that may influence the demand for bioactive materials in the near future and latest trends of the market have also been studied.
Bioactive materials provide the appropriate biological response between material and tissue that result in the formation of a bond between them. Bioactive materials are used to manufacture products that have the ability to replace a part of the body in a physiologically safe and economical manner. Moreover, bioactive materials are able to integrate with cells or biological molecules for tissue regeneration. They are also used for the development of bone graft substitutes for bone and joint reconstructive surgeries.
The rising aging population across the world is considered as the primary driver for the global bioactive materials market. The World Health Organization (WHO) estimates that the global geriatric population could increase to as much as 2 bn by the end of 2050. Additionally, the global geriatric population is likely to grow at a very fast rate in developed countries such as the U.S., the U.K., and Japan, over emerging ones. However, the high cost of new technologies and an increased use of synthetic materials in grafting technique are crucial factors that would restrict the global bioactive materials market.
There are three primary bioactive materials currently available in the market: polymer-based, metallic-based and ceramic-based bioactive materials. Polymer-based bioactive materials are biodegradable products – natural or synthetic – such as collagen fibrin, hyaluronic acid, and chitosan that can exhibit excellent osteo-conductive and biocompatibility properties. Metallic-based bioactive materials such as titanium and tantalum are widely used for bone and joint reconstructive surgeries due to good corrosion resistance, biocompatibility, and durability. Glass and glass ceramics made from calcium phosphates, calcium sulfates, and bioactive glass are widely utilized as ceramic bioactive materials in medical science.
North America represented the leading regional market for demand volume of bioactive materials, primarily due to the introduction of technologically advanced medical devices and an increase in orthopedic surgeries. The American Academy of Orthopedic Surgeons (AAOS) estimated that, approximately 2.4 mn people in the U.S. would be affected by LSS by 2021. Europe holds second place in this market due to the region’s exceptionally fast-growing geriatric population and increase in life expectancy, as well as a growing prevalence of musculoskeletal diseases. According to the National Healthcare Service (NHS), around 10 mn people in the U.K. have arthritis, out of which 8.5 mn suffer from osteoarthritis.
Japan and China account for the leading share in the bioactive materials market within Asia Pacific. The Government of Japan stated that it holds the lead in the growth rate of geriatric population in Asia which reached a record of 31.86 mn people in September 2013. The population is expected to reach 95.2 mn by 2050. This significant rise in the geriatric population along with the technological advancement is expected to boost the bioactive materials market in this region. The rest of the world comprises Latin America and The Middle East and Africa. A significant increase in athletic involvement and physical activities has increased the risk of injuries in sports-loving countries such as Brazil and Mexico. The governments of Brazil and Mexico are focusing on reducing overall healthcare expenditure in order to make the surgeries easily accessible at a low cost and thereby enhance the chances of an increase in the uptake of bioactive materials.
Major players operating in this market include Baxter International, Inc., Smith & Nephew PLC, CONMED Corporation, DePuy Synthes, Inc., Arthrex, Inc., Medtronic, Inc., Stryker Corporation, and Zimmer Holdings, Inc.
The study presents a granular assessment and quantitative evaluation of:
The region-wise assessment includes market dynamics in:
The study is prepared with the help of an extensive primary and secondary research. Primary research includes but not limited to interactions, interviews, surveys, and events. Opinions of policy makers and industry experts are carefully integrated into the insights to complement primary research. Volumes of secondary data gleaned through renowned paid sources, annual statements, reputed journals, and government documents offer insights into current dynamics and key evolution trajectories the market is likely to assume. The research employs various industry-wide analytics methods and well-established methodologies to ascertain the attractiveness of key segments. Further, it evaluates the lucrativeness of key regions and factors underlying their maturity. The insights notably include a detailed analysis of forces behind vendor differentiation and offers insight into investment-decision making by prominent players.
The report strives to enlighten businesses and industry stakeholders on multiple facets of the growth dynamic of the market, the key of which include answers to:
Note: Utmost care has invariably been taken to present data and arrive at statistics at all the TMR Research reports. Meanwhile, some recent developments and new industry trends may take time to be included in the reports.
Flat 10% discount on Single User License if you prebook this report
Flat 10% discount on Multiple User License if you prebook this report
Flat 10% discount on Corporate License if you prebook this report